BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD. Financials Beijing Kawin Technology Share-Holding Co., Ltd.
Equities
688687
CNE1000054C3
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.61 CNY | -0.47% |
|
-7.08% | -26.53% |
| 04-10 | China stocks down pressured by real estate; HK shares up | RE |
| 04-09 | Beijing Kawin Technology Share-Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 3,888 | 5,837 | 4,288 | - | - |
| Enterprise Value (EV) 1 | 3,888 | 5,837 | 4,288 | 4,288 | 4,288 |
| P/E ratio | 46.4 x | 50.3 x | 29.6 x | 22.1 x | 16.3 x |
| Yield | - | 0.72% | 1.23% | 1.76% | 2.19% |
| Capitalization / Revenue | - | 4.13 x | 2.51 x | 1.95 x | 1.55 x |
| EV / Revenue | - | 4.13 x | 2.51 x | 1.95 x | 1.55 x |
| EV / EBITDA | - | 30.5 x | 18.4 x | 13.8 x | 10.3 x |
| EV / FCF | - | - | 34.7 x | 27.1 x | 19.6 x |
| FCF Yield | - | - | 2.88% | 3.69% | 5.1% |
| Price to Book | - | 3.4 x | 2.34 x | 2.18 x | 1.98 x |
| Nbr of stocks (in thousands) | 170,908 | 167,435 | 167,435 | - | - |
| Reference price 2 | 22.75 | 34.86 | 25.61 | 25.61 | 25.61 |
| Announcement Date | 2/22/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1,412 | 1,709 | 2,196 | 2,763 |
| EBITDA 1 | - | 191.3 | 233.3 | 311.7 | 418.3 |
| EBIT 1 | - | 170.4 | 206.9 | 280.2 | 375.9 |
| Operating Margin | - | 12.07% | 12.11% | 12.76% | 13.61% |
| Earnings before Tax (EBT) 1 | - | 145.9 | 195.9 | 268.7 | 363.9 |
| Net income 1 | 83.83 | 116.1 | 148 | 198.1 | 268.2 |
| Net margin | - | 8.22% | 8.66% | 9.02% | 9.71% |
| EPS 2 | 0.4900 | 0.6930 | 0.8640 | 1.158 | 1.570 |
| Free Cash Flow 1 | - | - | 123.4 | 158.2 | 218.6 |
| FCF margin | - | - | 7.22% | 7.2% | 7.91% |
| FCF Conversion (EBITDA) | - | - | 52.89% | 50.76% | 52.26% |
| FCF Conversion (Net income) | - | - | 83.38% | 79.86% | 81.49% |
| Dividend per Share 2 | - | 0.2500 | 0.3150 | 0.4500 | 0.5600 |
| Announcement Date | 2/22/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - |
| Net Cash position | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | - | 123 | 158 | 219 |
| ROE (net income / shareholders' equity) | - | 6.78% | 8% | 9.98% | 12.3% |
| ROA (Net income/ Total Assets) | - | 4.97% | 5.26% | 6.02% | 7% |
| Assets 1 | - | 2,335 | 2,813 | 3,291 | 3,832 |
| Book Value Per Share 2 | - | 10.30 | 10.90 | 11.80 | 12.90 |
| Cash Flow per Share 2 | - | 0.7400 | 0.8500 | 1.640 | 1.530 |
| Capex 1 | - | 154 | 98.8 | 113 | 120 |
| Capex / Sales | - | 10.9% | 5.78% | 5.16% | 4.35% |
| Announcement Date | 2/22/23 | 2/23/24 | - | - | - |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
25.61
CNY
Average target price
39.66
CNY
Spread / Average Target
+54.85%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -26.53% | 593M | |
| +16.49% | 122B | |
| +21.73% | 116B | |
| +22.18% | 27.03B | |
| -21.81% | 20.36B | |
| -16.89% | 16.43B | |
| -18.81% | 15.91B | |
| -44.74% | 15.6B | |
| +62.72% | 14.94B | |
| +3.09% | 13.59B |
- Stock Market
- Equities
- 688687 Stock
- Financials Beijing Kawin Technology Share-Holding Co., Ltd.
